Revance Therapeutics Inc (RVNC)
5.80
-0.10
(-1.69%)
USD |
NASDAQ |
Nov 01, 16:00
5.795
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Profit Margin (Quarterly): -57.31% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -57.31% |
| March 31, 2024 | -102.3% |
| December 31, 2023 | -79.80% |
| September 30, 2023 | -248.7% |
| June 30, 2023 | -123.6% |
| March 31, 2023 | -130.6% |
| December 31, 2022 | -292.4% |
| September 30, 2022 | -291.9% |
| June 30, 2022 | -217.7% |
| March 31, 2022 | -254.7% |
| December 31, 2021 | -243.2% |
| September 30, 2021 | -376.7% |
| June 30, 2021 | -383.9% |
| March 31, 2021 | -538.7% |
| December 31, 2020 | -703.4% |
| September 30, 2020 | -2.12K% |
| June 30, 2020 | -20.26K% |
| March 31, 2020 | -106.8K% |
| December 31, 2019 | -50.93K% |
| September 30, 2019 | -90.02K% |
| June 30, 2019 | |
| March 31, 2019 | -12.70K% |
| December 31, 2018 | -8.34K% |
| September 30, 2018 | -1.39K% |
| Date | Value |
|---|---|
| June 30, 2018 | -4.97K% |
| March 31, 2018 | -18.15K% |
| December 31, 2017 | -97.05K% |
| September 30, 2017 | -40.87K% |
| June 30, 2017 | -35.83K% |
| March 31, 2017 | -36.21K% |
| December 31, 2016 | -35.74K% |
| September 30, 2016 | -23.97K% |
| June 30, 2016 | -32.80K% |
| March 31, 2016 | -26.52K% |
| December 31, 2015 | -29.46K% |
| September 30, 2015 | -25.57K% |
| June 30, 2015 | -22.41K% |
| March 31, 2015 | -20.54K% |
| December 31, 2014 | -18.95K% |
| September 30, 2014 | -18.64K% |
| June 30, 2014 | -17.74K% |
| March 31, 2014 | -13.56K% |
| December 31, 2013 | -3.26K% |
| September 30, 2013 | -5.62K% |
| June 30, 2013 | -15.77K% |
| March 31, 2013 | -28.88K% |
| December 31, 2012 | -9.32K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-106.8K%
Minimum
Mar 2020
-57.31%
Maximum
Jun 2024
-9.69K%
Average
-291.9%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | -677.2% |
| Moderna Inc | -578.7% |
| Pacira BioSciences Inc | 10.61% |
| PetIQ Inc | 4.66% |
| Anebulo Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -55.05% |
| Return on Invested Capital | -87.72% |
| Gross Profit Margin (Quarterly) | 73.03% |
| Operating Margin (Quarterly) | -52.79% |
| Return on Net Operating Assets | -149.3% |